RxDoctor Payments Data

Ashley Pippin

Family · Dothan, ALNPI 1326444589

Payments from drug & device makers

$1,088in general payments, 2019–2025

Across 53 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$156
  • GSK$130
  • AbbVie$106
  • Corium, LLC$92
  • Corcept Therapeutics$88
  • Medtronic$59
  • plus $457 from 16 others

What the payments were for

  • Food & beverage$1,088100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,088 in reported general payments places this provider in the 65th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$53,510
MounjaroTirzepatide43$46,466
EliquisApixaban35$35,875
XareltoRivaroxaban36$28,026
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$20,752
JardianceEmpagliflozin23$19,193
LinzessLinaclotide24$17,709
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$8,208
VascepaIcosapent Ethyl16$5,662
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$3,181
Atorvastatin Calcium155$1,878
Fenofibrate19$1,776
Pantoprazole Sodium140$1,458
Levothyroxine Sodium95$1,421
Omeprazole65$1,398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$53,51054 claims
PfizerEliquis$37$35,87535 claims
GSKTrelegy Ellipta, Anoro Ellipta$130$28,95950 claims
Johnson & JohnsonXarelto$156$28,02636 claims
Boehringer IngelheimJardiance$48$19,19323 claims
AbbVieLinzess$106$17,70924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,415 family providers in Alabama.

Other family in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →